Phase I safety data of lenalidomide, bortezomib, dexamethasone and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase I safety data of lenalidomide, bortezomib, dexamethasone and elotuzumab as induction therapy for newly diagnosed symptomatic multiple myeloma: SWOG S1211
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 5, Issue 8, Pages e334-e334
Publisher
Springer Nature
Online
2015-08-07
DOI
10.1038/bcj.2015.62
References
View 5 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.